Ingredient portfolio
Difficult actives, made formulation-ready.
From z-curcumin to CoQ10, creatine, resveratrol and quercetin, the portfolio is designed around the constraints of real foods, beverages and supplements.
Lead ingredient
z-curcumin
zolvia.'s first validated ingredient tackles three separate barriers: clinical absorption, digestive bioaccessibility and aqueous solubility.
Absorption values are relative AUC versus native curcumin in a 500 mg pharmacokinetic study. They are not measures of health outcomes.
Review the clinical trialAvailable portfolio
Select an ingredient.
Each ingredient carries its own development status and its own evidence. Nothing shown here is a health claim.
z-curcumin
The lead validated ingredient, supported by human pharmacokinetic data, in-vitro bioaccessibility work and an aqueous-solubility improvement exceeding 24,000-fold.
Evidence
Human pharmacokinetic study: relative AUC up to 71× (powder) and 66× (liquid) versus native curcumin at a 500 mg dose, plus in-vitro bioaccessibility work and an aqueous-solubility improvement exceeding 24,000-fold.
Measures of absorption and solubility, not health outcomes. Results apply to z-curcumin only and are not transferable to other ingredients.
Under validation
The pipeline
These ingredients are being validated and are not presented as currently available.
Ready to make your ingredients perform in the finished product?
Speak with our team about your ingredient, product and application — and see how the platform can support your workflow.